Leave With Practical, Actionable Strategies to Move from AI Experimentation to Enterprise-Wide Value Creation by Linking AI-Driven Transformation, Workforce Planning & Leadership Enablement to Rethink Skills, Redesign Work & Deliver Measurable ROI at Scale
AI has moved beyond experimentation in life sciences. Every organization is racing to unlock the potential of AI, with industry investment in AI solutions almost doubling year-on-year to $207M in 2026, an increase from the $114M invested in 2025, according to KPMG's AI in Action for Life Sciences report.
The challenges are now:
- Translating pilot project adoption at scale
- Measuring business value and workforce productivity
- Enabling operating model transformation and sustainable change
What is clear is that the organizations creating the biggest advantage are acting now. They are reimagining how work gets done, redesigning roles around human-AI collaboration, and building the skills, capabilities, and workforce strategies needed to thrive in today's AI-enabled era. This forum shines a light on how leading biopharma are making that transformation a reality.
Featuring leaders from organizations including Genentech, Merck, Sanofi, Novartis, Takeda, Gilead, Vertex, Insmed, and many more, the Designing the AI-Enabled Life Sciences Workforce Summit returns as the only industry-specific forum dedicated to helping CHROs, strategic HR, workforce strategy, and transformation leaders move from AI ambition to demonstrable enterprise-wide ROI.
Join CHROs, Heads of People Strategy, Talent, Analytics, Organizational Effectiveness, Transformation, and Workforce Strategy to benchmark and pressure-test your thinking. Leave with practical strategies to redesign work, accelerate AI adoption at scale, increase organizational efficiency, and build the AI-enabled workforce that you need.
Attending Companies Include